Humacyte Inc. (NASDAQ: HUMA)
$8.47
-0.3200 ( -3.64% ) 1.1M
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
Market Data
Open
$8.47
Previous close
$8.79
Volume
1.1M
Market cap
$1.01B
Day range
$8.35 - $8.86
52 week range
$1.96 - $9.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 04, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | Jun 03, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
4 | Insider transactions | 1 | May 15, 2024 |
10-q | Quarterly Reports | 76 | May 13, 2024 |
8-k | 8K-related | 16 | May 10, 2024 |